These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29030766)

  • 21. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results.
    Abboud H; Rossman I; Mealy MA; Hill E; Thompson N; Banerjee A; Probasco J; Levy M
    J Neurol; 2017 Nov; 264(11):2284-2292. PubMed ID: 28975404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hu, Yo, Ri, Ma, Ta: monosyllabic answers to complex questions.
    Verschuuren J
    J Neurol Neurosurg Psychiatry; 2008 Jul; 79(7):742. PubMed ID: 18559456
    [No Abstract]   [Full Text] [Related]  

  • 24. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraneoplastic neurological syndromes.
    Sillevis Smitt P
    Lancet Neurol; 2002 Nov; 1(7):408; discussion 408. PubMed ID: 12849362
    [No Abstract]   [Full Text] [Related]  

  • 26. The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested.
    Ruiz-García R; Martínez-Hernández E; Saiz A; Dalmau J; Graus F
    Front Immunol; 2020; 11():1482. PubMed ID: 32760403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immunoprecipitation assay for the detection of onconeural antibodies.
    Monstad SE; Vedeler CA
    Acta Neurol Scand Suppl; 2006; 183():71-2. PubMed ID: 16637936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
    Raspotnig M; Vedeler C; Storstein A
    J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Paraneoplastic neurological syndromes].
    Storstein A; Vedeler CA
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):524-8. PubMed ID: 19282889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies against glial antigens in paraneoplastic neurological diseases.
    Tschernatsch M; Gross O; Kneifel N; Krasenbrink I; Gerriets T; Kaps M; Blaes F
    Ann N Y Acad Sci; 2007 Jun; 1107():104-10. PubMed ID: 17804537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraneoplastic Neurological Syndromes: A Condition of Increasing Recognition.
    Seluk L; Kivity S
    Isr Med Assoc J; 2018 Oct; 20(10):649-650. PubMed ID: 30324785
    [No Abstract]   [Full Text] [Related]  

  • 32. [Paraneoplastic neurological syndromes].
    Stich O; Rauer S
    Nervenarzt; 2013 Apr; 84(4):455-60. PubMed ID: 23443876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recommended diagnostic criteria for paraneoplastic neurological syndromes.
    Graus F; Delattre JY; Antoine JC; Dalmau J; Giometto B; Grisold W; Honnorat J; Smitt PS; Vedeler Ch; Verschuuren JJ; Vincent A; Voltz R
    J Neurol Neurosurg Psychiatry; 2004 Aug; 75(8):1135-40. PubMed ID: 15258215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric manifestations of paraneoplastic disorders.
    Kayser MS; Kohler CG; Dalmau J
    Am J Psychiatry; 2010 Sep; 167(9):1039-50. PubMed ID: 20439389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing paraneoplastic neurological disorders.
    de Beukelaar JW; Sillevis Smitt PA
    Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune channelopathies in paraneoplastic neurological syndromes.
    Joubert B; Honnorat J
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Paraneoplastic neurological syndromes].
    Rauer S
    Fortschr Neurol Psychiatr; 2011 Jan; 79(1):51-8; quiz 59-61. PubMed ID: 21240836
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes.
    Storstein A; Raspotnig M; Vitaliani R; Giometto B; Graus F; Grisold W; Honnorat J; Vedeler CA
    J Neurol; 2016 May; 263(5):1001-1007. PubMed ID: 27007485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paraneoplastic neurological syndromes: from the diagnosis of exclusion to the use of immunological and molecular markers].
    Dalmau J
    Neurologia; 2000 Mar; 15(3):114-26. PubMed ID: 10846872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization Review of Paraneoplastic Neurological Syndrome Antibody Screening Panels: Experience at a Tertiary Academic Health Center.
    Kim JT; Harris NS
    J Appl Lab Med; 2019 Jul; 4(1):19-29. PubMed ID: 31639704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.